Expression of angiopoietins and its clinical significance in non-small cell lung cancer

Cancer Research

Volumn 62, Issue 23, 2002, Pages 7124-7129

  Tanaka, Fumihiro ^a   Ishikawa, Shinya ^a   Yanagihara, Kazuhiro ^a   Miyahara, Ryo ^a   Kawano, Yozo ^a   Li, Mio ^a   Otake, Yosuke ^b   Wada, Hiromi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Seishin Iryo Center Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANTIGEN; CD34 ANTIGEN; ENDOGLIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

AGED; ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036896832     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Folkman, J., Watson, K., Ingiber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.), 339: 58-61, 1989.
2. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S, J., and Holash, J. Vascular-specific growth factors and blood vessel formation. Nature (Lond.), 407: 242-248, 2000.
3. Cox, G., Jones, J. L., Walker. R. A., Steward, W. P., and O'Byrne K. J. Angiogenesis and non-small cell lung cancer. Lung Cancer, 27: 81-100, 2000.
4. Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J, Radziejewski, C., Mainsonpierre, P. C., and Yancopoulos, G. D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 87: 1161-1169, 1996.
5. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Mainsonpierre, P. C., Davis, S., Sato, T. N., and Yancopoulos, G. D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87: 1171-1180, 1996.
6. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand. S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Davis. S., Sato. T. N., and Yancopoulos, G. D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (Wash. DC), 277: 55-60.
7. Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., and Wiegand, S. J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science (Wash. DC), 284: 1994-1998, 1999.
8. Ahmad, S. A., Liu, W., Jung, Y. D., Fan, F., Wilson, M., Reinmuth, N., Shaheen, R. M., Bucana, C. D., and Ellis, L. M. The effect of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res., 61: 1255-1259, 2001.
9. Yu, Q., and Stamenkovic. Angiopoietin-2 is implicated in regulation of tumor angiogenesis. Am. J. Pathol., 158: 563-570, 2001.
10. Koga, K., Todaka, T., Morioka, M., Hamada, J., Kai, Y., Yano, S., Okamura, A., Takakura, N., Suda, T., and Ushio, Y. Expression of angiopoieton-2 in human glioma cells and its role for angiogenesis. Cancer Res., 61: 6248-6254, 2001.
11. Stratmann, A., Risau, W., and Plate, K. H. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol., 153: 1459-1466, 1998.
12. Eggert, A., Ikegami, N., Kwiatkowski, J., Zhao, H., Brodeur, G. M., and Himelstein, B. P. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin. Cancer Res., 6: 1900-1908, 2000.
13. Ahmad, S. A., Liu, W., Jung, Y. D., Fan, F., Reinmuth, N., Bucana, C. D., and Ellis, L. M. Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. Cancer (Phila.). 92: 1138-1143, 2001.
14. Etoh, T., Inoue, H., Tanaka, S., Barnard, G. F., Kitano. S., and Mori, M. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: Possible in vivo regulation via induction of proteases. Cancer Res., 61: 2145-2153, 2001.
15. Tanaka, S., Mori, M., Sakamoto. Y., Makuuchi, M., Sugimachi, K., and Wands, J. R. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J. Clin. Investig., 103: 341-345, 1999.
16. Takahama. M., Tsutsumi, M., Tsujiuchi, T., Nezu, K., Kushibe, K., Taniguchi, S., Kotake. Y., and Konishi, Y. Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas. Clin. Cancer Res., 5: 2506-2510, 1999.
17. Wong, M. P., Chan, S. Y., Fu, K. H., Leung, S. Y., Cheung, N., Yuen, S. T., and Chung, L. P. The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas. Lung Cancer, 29: 11-22, 2000.
18. Hatanaka, H., Abe. Y., Naruke, M., Tokunaga, T., Oshita, Y., Kawakami, T., Osada, H., Nagata, J., Kamochi. J., Tsuchida, T., Kijima, H., Yamazaki, H., Inoue, H., Ueyama, Y., and Nakamura, M. Significant correlation between interleukin 10 expression and vascularization through angiopoietin/Tie2 networks in non-small cell lung cancer. Clin. Cancer Res., 7: 1287-1292, 2001.
19. Tanaka, F., Otake, Y., Yanagihara, K., Kawano, Y., Miyahara, R., Li, M., Yamada, T., Hanaoka, N., Inui, K., and Wada, H. Evaluation of angiogenesis in non-small cell lung cancer: Comparison between anti-CD34 antibody and anti-CD105 antibody. Clin. Cancer Res., 7: 3410-3415, 2001.
20. Tanaka, F., Kawano, Y., Li, M., Takata, T., Miyahara, R., Yanagihara, K., Ohtake, Y., Fukuse, T., and Wada, H. Prognostic significance of apoptotic index in completely resected non-small cell lung cancer. J. Clin. Oncol., 17: 2728-2736, 1999.
21. Tanaka, F., Yanagihara, K., Ohtake. Y., Miyahara, R., Kawano, Y., Fukuse. T., Hitomi, S., and Wada, H. p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer. Jpn. J. Cancer Res., 90: 432-438, 1999.
22. Mountain, C. F. Revisions in the international system for lung cancer. Chest, 111: 1710-1717, 1997.
23. Travis, W. D., Colby, T. V., Corrin, B., Shimosato, Y., and Brambilla, E. Histological typing of lung and pleural tumors, In: W. D. Travis (ed.), World Health Organization International Histological Classification of Tumors. Histological Typing of Lung and Pleural Tumors, Ed. 3., pp. 21-66. Berlin: Springer, 1999.
24. Kumar, P., Wang, J. M., and Bernabeu, C. CD105 and angiogenesis. J. Pathol., 178: 363-366, 1996.
25. Kumar, S., Ghellal, A., Li, C., Byrne, G., Haboubi, N., Wang, J. M., and Bundred, N. Breast carcinoma: Vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res., 59: 856-861, 1999.
26. Brown, L. F., Dezube, B. J., Tognazzi, K., Dvorak, H. F., and Yancopoulos, G. D. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am. J. Pathol. 156: 2179-2183, 2000.